SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:SuppreMol GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013265
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. Its antibody is used to restrict cellular activation signals mediated by the B cell receptor. SuppreMol also works on anti-Fc?RIIb antibodies, which can be useful for the treatment of autoimmune diseases(and allergic reactions . The company conducts research and development to develop new drugs. SuppreMol is headquartered in Munich, Germany.

SuppreMol GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SuppreMol GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Suppremol Raises US$20.6 Million In Series D Financing 10
Licensing Agreements 11
SuppreMol Exercises Option For Licensing Agreement With Bayerische For RA Antibody 11
Acquisition 13
Baxter International Acquires SuppreMol for USD225 Million 13
SuppreMol GmbH – Key Competitors 14
SuppreMol GmbH – Key Employees 15
SuppreMol GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SuppreMol GmbH, Pharmaceuticals & Healthcare, Key Facts 2
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SuppreMol GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SuppreMol GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
SuppreMol GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Suppremol Raises US$20.6 Million In Series D Financing 10
SuppreMol Exercises Option For Licensing Agreement With Bayerische For RA Antibody 11
Baxter International Acquires SuppreMol for USD225 Million 13
SuppreMol GmbH, Key Competitors 14
SuppreMol GmbH, Key Employees 15

★海外企業調査レポート[SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Unichem Laboratories Ltd (UNICHEMLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • Multan Electric Power Company:企業の戦略的SWOT分析
    Multan Electric Power Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • AU Optronics Corp (2409):電力:M&Aディール及び事業提携情報
    Summary AU Optronics Corp. (AUO) is a provider of optoelectronic solutions. The company designs, develops, manufactures and assembles a wide range of panel display products. Its panels are primarily used in televisions, monitors, mobile PCs, mobile devices and commercial and other applications. It m …
  • Eskom Uganda Ltd:企業の戦略的SWOT分析
    Eskom Uganda Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Heron Therapeutics Inc (HRTX):企業の財務・戦略的SWOT分析
    Heron Therapeutics Inc (HRTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • E.ON SE Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    E.ON SE Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary E.ON SE(E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports and supplies gas, and conducts trading, carbon sourcing, and electricity and gas distribution. It ge …
  • Brembo SpA:戦略・SWOT・企業財務分析
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cornerstone Capital Resources Inc (CGP):企業の財務・戦略的SWOT分析
    Summary Cornerstone Capital Resources Inc (Cornerstone) operates as a mining and mineral exploration and development company that offers mineral resources. The company offers acquisition, exploration, management, operations, production, mining, and development of rare earth elements, nickel, uranium …
  • Bangkok Dusit Medical Services PCL (BDMS):製薬・医療:M&Aディール及び事業提携情報
    Summary Bangkok Dusit Medical Services PCL (BDMS) is a private hospital operator that offers healthcare services. It provides medical services and patient services in various therapeutic areas through its medical centers. BDMS operates its business through a network of hospitals namely, Bangkok Hosp …
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Petrolina (Holdings) Public Ltd (PHL):企業の財務・戦略的SWOT分析
    Petrolina (Holdings) Public Ltd (PHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Bawag Psk:企業の戦略・SWOT・財務分析
    Bawag Psk - Strategy, SWOT and Corporate Finance Report Summary Bawag Psk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Swedish Orphan Biovitrum AB (SOBI):企業の財務・戦略的SWOT分析
    Swedish Orphan Biovitrum AB (SOBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Galenica Ltd:企業の戦略・SWOT・財務情報
    Galenica Ltd - Strategy, SWOT and Corporate Finance Report Summary Galenica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Federal Signal Corp (FSS):企業の財務・戦略的SWOT分析
    Federal Signal Corp (FSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • StealthGas Inc (GASS):企業の財務・戦略的SWOT分析
    Summary StealthGas Inc (StealthGas) is an oil and gas shipping company that offers seaborne and oil and gas transportation services. The company provides transportation of petroleum and petrochemical gas products in liquefied forms. StealthGas transports byproducts of crude oil and natural gas inclu …
  • Stanwell Corp Ltd:企業の戦略的SWOT分析
    Stanwell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Insulet Corp (PODD):企業の財務・戦略的SWOT分析
    Insulet Corp (PODD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆